Immunoglobulin Negative Control (Primary Antibody) - ANVISA Registration 10287411753

Access comprehensive regulatory information for Immunoglobulin Negative Control (Primary Antibody) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10287411753 and manufactured by VENTANA MEDICAL SYSTEM, INC. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.